GILL, P. S.; GREWAL, N. Mirabegron: first β3 agonist in treatment of overactive bladder. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 1, n. 2, p. 120–121, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/1410. Acesso em: 16 apr. 2026.